sb 203580 has been researched along with ent-crizotinib in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (ent-crizotinib) | Trials (ent-crizotinib) | Recent Studies (post-2010) (ent-crizotinib) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 11 | 0 | 11 |
| Protein | Taxonomy | sb 203580 (IC50) | ent-crizotinib (IC50) |
|---|---|---|---|
| 7,8-dihydro-8-oxoguanine triphosphatase | Homo sapiens (human) | 0.5289 | |
| Mitogen-activated protein kinase kinase kinase kinase 3 | Homo sapiens (human) | 0.68 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Munoz, L | 1 |
1 review(s) available for sb 203580 and ent-crizotinib
| Article | Year |
|---|---|
Non-kinase targets of protein kinase inhibitors.
Topics: Animals; Drug Design; Drug Evaluation, Preclinical; Humans; Molecular Targeted Therapy; Protein Kinase Inhibitors; Protein Kinases | 2017 |